{
  "prompt": {
    "guidelineId": "cg1103-antenatal-care-patient-info-pdf",
    "fieldsProcessed": [
      "humanFriendlyName",
      "organisation",
      "yearProduced",
      "summary"
    ],
    "enhancedFields": 4,
    "contentLength": 5073
  },
  "response": "{\n  \"success\": true,\n  \"enhancedFields\": [\n    {\n      \"field\": \"humanFriendlyName\",\n      \"oldValue\": null,\n      \"newValue\": \"Antenatal Care Guidelines for Pregnant Women and Birthing People\",\n      \"action\": \"added\"\n    },\n    {\n      \"field\": \"organisation\",\n      \"oldValue\": null,\n      \"newValue\": \"RCOG\",\n      \"action\": \"added\"\n    },\n    {\n      \"field\": \"yearProduced\",\n      \"oldValue\": null,\n      \"newValue\": \"2023\",\n      \"action\": \"added\"\n    },\n    {\n      \"field\": \"summary\",\n      \"oldValue\": null,\n      \"newValue\": \"**Summary of Antenatal Care Guidelines:** - **Booking Appointment:** Conduct risk assessment, health promotion, and obtain consent for screening tests (e.g., Chlamydia/Gonorrhea for those ≤24). Document declined tests. - **Individualized Care:** Tailor care to each woman’s needs, involving partners if desired. Provide unbiased information and language support as needed. - **Screening & Tests:** Offer blood/urine tests, discuss blood product consent, and ensure proper documentation. Monitor for UTIs (urinalysis at each visit) and refer recurrent cases. - **Risk Assessment:** Update at each visit, referring high-risk women to consultants/specialists (e.g., mental health, safeguarding, FGM support). - **Lifestyle Advice:** Address smoking cessation, alcohol use, and weight management (BMI <30). - **Fetal Monitoring:** Track growth and wellbeing; refer for growth scans if concerns arise. Manage common pregnancy issues (e.g., nausea, bleeding). - **High-Risk Groups:** Closely monitor minority ethnic, deprived, or migrant women; ensure medical history review and additional support. - **Continuity & Coordination:** Maintain consistent care, clear communication, and accessible environments. Refer unexplained bleeding (<16 weeks to EPAC; ≥16 weeks to labour ward). - **Documentation:** Ensure records include test results, risk assessments, and specialist referrals. *References: MBRRACE-UK 2023; UK NSC guidelines.*\",\n      \"action\": \"added\"\n    }\n  ]\n}",
  "endpoint": "enhanceGuidelineMetadata",
  "timestamp": "2025-06-18T18-40-33",
  "textContent": "AI: DeepSeek (deepseek-chat)\n\nQ: {\n  \"guidelineId\": \"cg1103-antenatal-care-patient-info-pdf\",\n  \"fieldsProcessed\": [\n    \"humanFriendlyName\",\n    \"organisation\",\n    \"yearProduced\",\n    \"summary\"\n  ],\n  \"enhancedFields\": 4,\n  \"contentLength\": 5073\n}\n\nA: {\n  \"success\": true,\n  \"enhancedFields\": [\n    {\n      \"field\": \"humanFriendlyName\",\n      \"oldValue\": null,\n      \"newValue\": \"Antenatal Care Guidelines for Pregnant Women and Birthing People\",\n      \"action\": \"added\"\n    },\n    {\n      \"field\": \"organisation\",\n      \"oldValue\": null,\n      \"newValue\": \"RCOG\",\n      \"action\": \"added\"\n    },\n    {\n      \"field\": \"yearProduced\",\n      \"oldValue\": null,\n      \"newValue\": \"2023\",\n      \"action\": \"added\"\n    },\n    {\n      \"field\": \"summary\",\n      \"oldValue\": null,\n      \"newValue\": \"**Summary of Antenatal Care Guidelines:** - **Booking Appointment:** Conduct risk assessment, health promotion, and obtain consent for screening tests (e.g., Chlamydia/Gonorrhea for those ≤24). Document declined tests. - **Individualized Care:** Tailor care to each woman’s needs, involving partners if desired. Provide unbiased information and language support as needed. - **Screening & Tests:** Offer blood/urine tests, discuss blood product consent, and ensure proper documentation. Monitor for UTIs (urinalysis at each visit) and refer recurrent cases. - **Risk Assessment:** Update at each visit, referring high-risk women to consultants/specialists (e.g., mental health, safeguarding, FGM support). - **Lifestyle Advice:** Address smoking cessation, alcohol use, and weight management (BMI <30). - **Fetal Monitoring:** Track growth and wellbeing; refer for growth scans if concerns arise. Manage common pregnancy issues (e.g., nausea, bleeding). - **High-Risk Groups:** Closely monitor minority ethnic, deprived, or migrant women; ensure medical history review and additional support. - **Continuity & Coordination:** Maintain consistent care, clear communication, and accessible environments. Refer unexplained bleeding (<16 weeks to EPAC; ≥16 weeks to labour ward). - **Documentation:** Ensure records include test results, risk assessments, and specialist referrals. *References: MBRRACE-UK 2023; UK NSC guidelines.*\",\n      \"action\": \"added\"\n    }\n  ]\n}",
  "ai_provider": "DeepSeek",
  "ai_model": "deepseek-chat",
  "token_usage": null
}